IMPROVE-IT Study: Negative Panel Review Leaves FDA With Tough Choice

By Sue Sutter / Email http://www.expertliposuction.com/thermage/ the thermage face Author / View Full Issue Advisory Committees / Word Count: 1874 / Article # 00151221008 / Posted: December 21 2015 12:02 AM Approval of cardiovascular risk reduction claims for Merck's Zetia and Vytorin would fly in the face of advisory committee's recommendations, but rejection would mean the first outcomes…

http://feedproxy.google.com/~r/ThePinkSheet/~3/Tt8a9hrfHDw/IMPROVEIT-Study-Negative-Panel-Review-Leaves-FDA-With-Tough-Choice